Alana R. Amarosa1, Sungheon Kim1, Amy Melsaether1, Jason McKellop1, Melanie Moccaldi1, Linda Moy1
1Radiology, NYU School of Medicine, New York, United States
The purpose of this study is to investigate whether the amount of fibroglandular tissue on MRI and background parenchymal enhancement are associated with breast cancer risk. This retrospective study included 36 BRCA mutation carriers and 40 controls who underwent MRI-guided biopsy for an enhancing lesion. When comparing signal percent enhancement for pre- and post-menopausal BRCA carriers, we found a significant difference (p=0.04). Also, menopausal BRCA carriers had higher early enhancement rate than pre-menopausal BRCA carriers. No such difference was found between pre- and post-menopausal control groups. These findings substantiate our hypothesis that breast cancer risk is associated with breast density.